about
Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B.Prevalence of Metabolic Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-AnalysisGluten sensitivity enteropathy in patients with recurrent aphthous stomatitis.Distribution of different hepatitis C virus genotypes in patients with hepatitis C virus infectionA population based study on hepatitis B virus in northern iran, amolLow dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapyFatty liver index vs waist circumference for predicting non-alcoholic fatty liver diseasePatient-to-Patient Transmission of Hepatitis C at Iranian Thalassemia Centers Shown by Genetic Characterization of Viral Strains.Rural Residency has a Protective Effect and Marriage is a Risk Factor for NAFLD.Body Roundness Index and Waist-to-Height Ratio are Strongly Associated With Non-Alcoholic Fatty Liver Disease: A Population-Based Study.Prevalence and risk factors of hepatitis C virus infection in amol city, north of iran: a population-based study (2008-2011)Gluten sensitive enteropathy in patients with iron deficiency anemia of unknown origin.Coeliac disease in autoimmune liver disease: a cross-sectional study and a systematic review.Discriminatory Ability of Visceral Adiposity Index (VAI) in Diagnosis of Metabolic Syndrome: A Population Based Study.Comparison of cardiovascular risk assessment tools and their guidelines in evaluation of 10-year CVD risk and preventive recommendations: A population based study.The six obesity indices, which one is more compatible with metabolic syndrome? A population based study.Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.Parity, duration of lactation and prevalence of maternal metabolic syndrome: a cross-sectional study.Trace Element and Heavy Metal Levels in Colorectal Cancer: Comparison Between Cancerous and Non-cancerous Tissues.Investigation of FIH-1 and SOCS3 expression in KRAS mutant and wild-type patients with colorectal cancer.Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study.Prevalence of gastric precancerous lesions among chronic dyspeptic patients and related common risk factors.Lipid accumulation product and metabolic syndrome: a population-based study in northern Iran, Amol.Nonalcoholic Fatty Liver: The Association with Metabolic Abnormalities, Body Mass Index and Central Obesity--A Population-Based Study.Celiac disease as a potential cause of idiopathic portal hypertension: a case report.Periorbital Ecchymosis (Raccoon Eye) and Orbital Hematoma following Endoscopic Retrograde CholangiopancreatographyAssociation between Nicotinamide Phosphoribosyltransferase and de novo Lipogenesis in Nonalcoholic Fatty Liver Disease.Transient elastography in hepatitis C virus-infected patients with beta-thalassemia for assessment of fibrosis.Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.Metabolic syndrome and cardiovascular risk assessment tools' estimations of 10-year cardiovascular risk: a population-based study.HLA-DRB1 alleles of susceptibility and protection in Iranians with autoimmune hepatitis.Ergonomic design and evaluation of a diagnostic ultrasound transducer holder.Utility of endoscopic ultrasound to diagnose remnant stones in symptomatic patients after cholecystectomy.Metabolic Syndrome is Associated with Health-Related Quality of Life in Suspected Patients with Nonalcoholic Steatohepatitis.Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study.Conicity Index and Waist-to-Hip Ratio Are Superior Obesity Indices in Predicting 10-Year Cardiovascular Risk Among Men and Women.Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot studyPsoriasis and Coeliac Disease; Is There Any Relationship?Prevalence of Celiac Disease Among Patients with Behcet’s Disease in IranImproved design and protocol for evapoporometry determination of the pore-size distribution
P50
Q24816554-86299917-3FE8-4F06-9C8A-42E622EB8286Q26772266-E7688B64-C030-47B7-BFA5-5ED86B36E9A8Q33469936-3C3092AC-B297-4232-990E-2730B317A11DQ33812183-2AB2A323-7E6E-42D8-ADEF-A859637B53F6Q34196708-04DCB193-4042-4513-8349-34E309710461Q36142737-D33301E1-2279-42D9-ADA9-9D282681B6EAQ36656622-37BC22EA-F571-4E1E-B325-E441DA950761Q36754150-F41ED236-A036-4ACB-A20B-0A0B389CF914Q37246601-DCA92627-43A3-46B7-915D-EC305E08E048Q37387559-9EE6968D-90CA-493D-B0EA-567B11A26F14Q37401154-81C5349C-D2E9-4C08-B586-606BE2722541Q37423075-3E801547-D16D-411D-88D3-2F9A5C834841Q37710843-F7B6DA23-8004-4E7B-9D9D-6DAB83AD7F68Q38917293-788DC1C2-942B-4198-9163-05D95E3A118BQ39174114-80C17BAA-DAE1-4207-89CD-A78F16B9E719Q39361233-F86BACF9-D8A9-40E0-BBCB-8B716B97C228Q39420619-8FFF42EB-55DE-4801-892D-D215487D079DQ39851128-5CFAB06E-CDBE-4387-BCAD-05E396F1CA43Q40088238-811CA133-9C54-418B-880F-AA31A4B44650Q40125078-3E9D1DB9-B7C4-4747-8EB7-871847125208Q40156884-606D0E07-7B42-43C6-B4D2-3F9C328D2B20Q41188250-4435CCC7-A1C0-41A8-825B-9D5BE5D884F0Q41440377-D2AEC12B-4B02-4BF7-9F8D-EC5F687EB516Q41694718-65FC87C8-14D0-4B4D-8071-345976BBB8D5Q42130983-C28682BF-6EAB-49F8-BEB1-23C406CDFBC3Q42158508-01597A91-B150-44B2-ABF7-DE2400FBF095Q42756198-0B2855E6-F1F8-432A-9D0D-E05546A15D83Q45228282-D72574EC-4573-4FFC-8168-EDFBE50A276EQ45411408-F019162D-253B-4710-A9B4-5CC0A3BD557EQ47393422-CEEEABE3-E55B-4770-BE30-AC6F3092DF0BQ47822368-7CA12653-76CF-480C-8E77-2A3AE55F2BE0Q48128708-DAB7D366-3C98-4149-A941-C0DBC46D5E7AQ50182414-DDF0E985-5D39-4243-AE81-5814F0B36E92Q50198326-098291C0-2341-4F63-A12C-AF0DF46F3A0DQ51322171-51CCD584-A9B1-4C0F-8E7C-5063863C382BQ51703067-151131BA-6FEE-4E1C-9E50-8BBBE92F91C6Q57157097-D258B3C2-3322-4DBB-829D-21A2CC0EC7C0Q57157231-AF1F64A0-4D95-4199-926C-68AC1111299FQ57157267-21574C72-29D2-4D57-B6CF-C9321BFE8E4DQ59410599-60C7B066-0F35-4AF5-A53F-D6EDF4A4B16A
P50
description
researcher ORCID ID = 0000-0001-7409-3412
@en
wetenschapper
@nl
name
Farhad Zamani
@ast
Farhad Zamani
@en
Farhad Zamani
@es
Farhad Zamani
@nl
type
label
Farhad Zamani
@ast
Farhad Zamani
@en
Farhad Zamani
@es
Farhad Zamani
@nl
prefLabel
Farhad Zamani
@ast
Farhad Zamani
@en
Farhad Zamani
@es
Farhad Zamani
@nl
P106
P1153
24366100600
8852491400
P31
P496
0000-0001-7409-3412